Ledger.Open graph →
SEC Form D · filed January 11, 2016

C4 Therapeutics, Inc

Offering
$73.5M
Sold
$70.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

William M. Scalzulli · Cambridge, MADirectorKenneth M. Anderson · Cambridge, MADirectorMalcolm S. Salter · Cambridge, MADirectorAlain Cohen · Cambridge, MADirectorElena M. Prokupets · Cambridge, MADirectorRonald W. Kaiser · Cambridge, MADirectorMarc Cohen · Cambridge, MAExec · DirectorJason Fisherman · La Jolla, CAExec · DirectorMiles M. Stuchin · Cambridge, MADirectorBruce M. Downey · Cambridge, MADirectorJay M. Eastman · Ann Arbor, MIDirectorBihua M. Chen · Cambridge, MADirectorRonald W. Kaiser · Cambridge, MADirectorMarc Cohen · North Andover, MAExec · DirectorJason Fisherman · Cambridge, MAExec · DirectorMiles M. Stuchin · Cambridge, MADirectorWilliam M. Scalzulli · Cambridge, MADirectorKenneth M. Anderson · Cambridge, MADirectorMalcolm S. Salter · Cambridge, MADirectorBruce M. Downey · Cambridge, MADirectorJay M. Eastman · Ann Arbor, MIDirectorAlain Cohen · Cambridge, MADirectorElena M. Prokupets · Cambridge, MADirectorBihua M. Chen · Cambridge, MADirectorRonald W. Kaiser · Herndon, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗